Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Stock is 

SEC Filing Details

Document Details

Filing Date
Feb 2, 2018
Document Date
Feb 2, 2018
Form Description
An amendment to the SC 13G filing
Filing Group
3,4,5
Company
Agios Pharmaceuticals, Inc.
Issuer
AGIOS PHARMACEUTICALS INC